Sidoti & Co. analyst James Sidoti upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy.
Goldman Sachs Initiates Coverage On Exscientia with Buy Rating, Announces Price Target of $30
Goldman Sachs analyst Chris Shibutani initiates coverage on Exscientia (NASDAQ:EXAI) with a Buy rating and announces Price Target of $30.